▶ 調査レポート

血友病A及びB組換え因子補充療法の世界市場:市場規模・現状・予測

• 英文タイトル:Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。血友病A及びB組換え因子補充療法の世界市場:市場規模・現状・予測 / Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2019-2025 / QYR9ST03907資料のイメージです。• レポートコード:QYR9ST03907
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、血友病A及びB組換え因子補充療法の世界市場について調査・分析し、血友病A及びB組換え因子補充療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(血友病A、血友病B)、用途別(病院、診療所、外来手術センター)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の血友病A及びB組換え因子補充療法市場動向
・主要企業別マーケットシェア
・血友病A及びB組換え因子補充療法の種類別市場規模2014-2019
(血友病A、血友病B)
・血友病A及びB組換え因子補充療法の用途別市場規模2014-2019
(病院、診療所、外来手術センター)
・血友病A及びB組換え因子補充療法の北米市場:主要企業・種類別/用途別市場規模
・血友病A及びB組換え因子補充療法のヨーロッパ市場:主要企業・種類別/用途別市場規模
・血友病A及びB組換え因子補充療法の中国市場:主要企業・種類別/用途別市場規模
・血友病A及びB組換え因子補充療法の日本国内市場:主要企業・種類別/用途別市場規模
・血友病A及びB組換え因子補充療法の東南アジア市場:主要企業・種類別/用途別市場規模
・血友病A及びB組換え因子補充療法のインド市場:主要企業・種類別/用途別市場規模
・血友病A及びB組換え因子補充療法の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Pfizer、Novo Nordisk、Baxalta、Bayer、Biogen、CSL Behring、Emergent Biosolutions、Spark therapeutics、Uniqure)
・血友病A及びB組換え因子補充療法の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptoms include bleeding from any site of the body. Internal bleeding is fatal as internal bleeding inside the joint causes joint damage and inside the brain, causes brain damage and seizers. The disease is inherited in an X-linked recessive genetic pattern, therefore males are commonly affected with haemophilia while females are usually carriers of the disease. Haemophilia A is caused by the deficiency of clotting Factor VIII, whereas haemophilia B is caused by the deficiency of Factor IX. It is also known as Christmas disease. The disease management includes factor replacement therapy. Factor replacement therapy is the infusion of factor VIII and IX concentrates through injection to control bleeding. These factor concentrates come from two sources i.e. from human plasma or from genetically engineered cell line made by recombinant DNA technology.In 2018, the global Hemophilia A and B Recombinant Factor Replacement Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hemophilia A and B Recombinant Factor Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemophilia A and B Recombinant Factor Replacement Therapy development in United States, Europe and China.

The key players covered in this study
Pfizer
Novo Nordisk
Baxalta
Bayer
Biogen
CSL Behring
Emergent Biosolutions
Spark therapeutics
Uniqure

Market segment by Type, the product can be split into
Haemophilia A
Haemophilia B

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers 

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hemophilia A and B Recombinant Factor Replacement Therapy status, future forecast, growth opportunity, key market and key players.
To present the Hemophilia A and B Recombinant Factor Replacement Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hemophilia A and B Recombinant Factor Replacement Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Haemophilia A
1.4.3 Haemophilia B
1.5 Market by Application
1.5.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers 
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size
2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Growth Trends by Regions
2.2.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions (2014-2025)
2.2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Manufacturers
3.1.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players Head office and Area Served
3.3 Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product/Solution/Service
3.4 Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019)
4.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
5.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in United States
5.3 United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
5.4 United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

6 Europe
6.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
6.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in Europe
6.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
6.4 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

7 China
7.1 China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
7.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in China
7.3 China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
7.4 China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

8 Japan
8.1 Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
8.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in Japan
8.3 Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
8.4 Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
9.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in Southeast Asia
9.3 Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
9.4 Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

10 India
10.1 India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
10.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in India
10.3 India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
10.4 India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2014-2019)
11.2 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players in Central & South America
11.3 Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
11.4 Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.1.4 Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novo Nordisk
12.2.1 Novo Nordisk Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.2.4 Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.2.5 Novo Nordisk Recent Development
12.3 Baxalta
12.3.1 Baxalta Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.3.4 Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.3.5 Baxalta Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.4.4 Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 Biogen
12.5.1 Biogen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.5.4 Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.5.5 Biogen Recent Development
12.6 CSL Behring
12.6.1 CSL Behring Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.6.4 CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.6.5 CSL Behring Recent Development
12.7 Emergent Biosolutions
12.7.1 Emergent Biosolutions Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.7.4 Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.7.5 Emergent Biosolutions Recent Development
12.8 Spark therapeutics
12.8.1 Spark therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.8.4 Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.8.5 Spark therapeutics Recent Development
12.9 Uniqure
12.9.1 Uniqure Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
12.9.4 Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
12.9.5 Uniqure Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Hemophilia A and B Recombinant Factor Replacement Therapy Key Market Segments
Table Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Covered
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type 2014-2025
Figure Haemophilia A Figures
Table Key Players of Haemophilia A
Figure Haemophilia B Figures
Table Key Players of Haemophilia B
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers  Case Studies
Figure Hemophilia A and B Recombinant Factor Replacement Therapy Report Years Considered
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2025 (Million US$)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions 2014-2025 (Million US$)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions 2014-2019 (Million US$)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions 2014-2019
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions 2014-2019
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions 2019
Table Market Top Trends
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Manufacturers (2014-2019)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Manufacturers in 2018
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product/Solution/Service
Table Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Share by Type (2014-2019)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type (2014-2019)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Share by Application (2014-2019)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application (2014-2019)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application in 2018
Figure United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table United States Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table United States Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Figure Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table China Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-20189) (Million US$)
Table China Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table China Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Figure Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Figure Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Figure India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table India Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table India Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table India Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Figure Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Market Share (2018-2019)
Table Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2014-2019)
Table Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Pfizer Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Novo Nordisk Recent Development
Table Baxalta Company Details
Table Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Baxalta Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Baxalta Recent Development
Table Bayer Company Details
Table Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Bayer Recent Development
Table Biogen Company Details
Table Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Biogen Recent Development
Table CSL Behring Company Details
Table CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure CSL Behring Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table CSL Behring Recent Development
Table Emergent Biosolutions Company Details
Table Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Emergent Biosolutions Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Emergent Biosolutions Recent Development
Table Spark therapeutics Company Details
Table Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Spark therapeutics Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Spark therapeutics Recent Development
Table Uniqure Company Details
Table Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)(Million US$)
Figure Uniqure Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2014-2019)
Table Uniqure Recent Development
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Share by Regions (2019-2025)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Share by Regions in 2025
Figure United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Figure India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Product (2019-2025)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Product in 2025
Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2019-2025)
Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources